137 related articles for article (PubMed ID: 34405891)
1. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.
Bei Y; Chen X; Xu Q; Lv J; Hu J; Yang S
Drug Dev Res; 2022 Apr; 83(2):379-388. PubMed ID: 34405891
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
Guo W; Li W; Yuan L; Mei X; Hu W
Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511
[TBL] [Abstract][Full Text] [Related]
3. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
[TBL] [Abstract][Full Text] [Related]
4. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.
Chen D; Lin X; Zhang C; Liu Z; Chen Z; Li Z; Wang J; Li B; Hu Y; Dong B; Shen L; Ji J; Gao J; Zhang X
Cell Death Dis; 2018 Jan; 9(2):123. PubMed ID: 29374144
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
Liang W; Xia B; He C; Zhai G; Li M; Zhou J
Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
[TBL] [Abstract][Full Text] [Related]
6. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
[TBL] [Abstract][Full Text] [Related]
7. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
[TBL] [Abstract][Full Text] [Related]
8. Apatinib combined with Keytruda treatment induces apoptosis of gastric carcinoma cells through CES4/miR-616-5p/DUSP2 axis.
Zhang F; Yin Y; Xu W; Zhou Z; Sun X; Li P
Basic Clin Pharmacol Toxicol; 2021 Nov; 129(5):345-356. PubMed ID: 34365722
[TBL] [Abstract][Full Text] [Related]
9. Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL‑6/JAK/STAT3‑mediated PD‑L1 activity.
Feng X; Xue F; He G; Ni Q; Huang S
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278452
[TBL] [Abstract][Full Text] [Related]
10. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
11. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
[TBL] [Abstract][Full Text] [Related]
12. Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer.
Chen J; Deng S; Zhang Y; Wang C; Hu X; Kong D; Liang G; Yuan X; Li Y; Wang X
Ann Transl Med; 2021 Jun; 9(12):1001. PubMed ID: 34277801
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
Liu YY; Zhang LY; Du WZ
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
[TBL] [Abstract][Full Text] [Related]
14. AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel.
Wu G; Qin XQ; Guo JJ; Li TY; Chen JH
Int J Clin Exp Pathol; 2014; 7(4):1449-58. PubMed ID: 24817940
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway.
Ma J; Song X; Xu X; Mou Y
Cancer Res Treat; 2019 Jan; 51(1):194-210. PubMed ID: 29690750
[TBL] [Abstract][Full Text] [Related]
16. Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer.
Luo PQ; Zhang LX; Chen ZM; Wang G; Zhu H; Ying S; Wei ZJ; Han WX; Xu AM
Cell Cycle; 2023 Jun; 22(12):1463-1477. PubMed ID: 37272203
[TBL] [Abstract][Full Text] [Related]
17. Anti-Gastric Cancer Effect of Purified
Xu Y; Xu W; Lu Z; Cheung MH; Lin M; Liang C; Lou J; Chen Y
Nutr Cancer; 2022; 74(5):1780-1791. PubMed ID: 34601984
[TBL] [Abstract][Full Text] [Related]
18. Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway.
Xie Q; Wang J; Wu W; Zhao Y
Am J Transl Res; 2022; 14(1):421-431. PubMed ID: 35173861
[TBL] [Abstract][Full Text] [Related]
19. d-Carvone inhibits the JAK/STAT3 signaling pathway and induced the apoptotic cell death in the human gastric cancer AGS cells.
Lv L; Yang N; Cao Y; Dang J; Cheng L; El-Sheikh MA; Zhang Y
J Biochem Mol Toxicol; 2021 May; 35(5):e22746. PubMed ID: 33661530
[TBL] [Abstract][Full Text] [Related]
20. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
